Clinical Trial Update: Intravenous Exenatide in Patients With Acute Brain Injury [Phase 4]

View source ↗

Summary

Phase 4 study update for intravenous exenatide in patients with acute brain injury, with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Brain Injury

Drugs mentioned

• EXENATIDE (EXENATIDE)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Brain Injuries | Phase 4 | Status: COMPLETED | Results posted: 2018-07-12